A West Lothian dad, who is raising thousands of pounds to take his daughter abroad for specialist treatment after she was told she would be in a wheelchair for the rest of her life, has been offered a discount by a top doctor.
The last one-and-a-half years have forced many individuals to reexamine their health and lifestyle choices, and this shift will influence medical travel decisions in the post-COVID-19 era. Here are the top three pull factors that will drive medical tourism success in the new normal:
Cleveland Clinic has been awarded “Accreditation with Excellence” for its medical travel services by Global Healthcare Accreditation (GHA) for a second consecutive term.
When clients contact the Super Antibacterial Mask Medical Material Production Joint Stock Company to purchase medical-grade personal protective equipment against COVID-19, they do so expecting the products to be shipped in time to protect as many as they can from the scourge of the coronavirus. But that doesn’t happen; what often follows is the sudden disappearance of the sellers and no shipment made, or at best, delivery of used condoms and gloves.
Vaccine supply mismatch has created a huge demand for COVID-19 vaccines in many low and middle-income countries. Consequently, this has spurred tourism stakeholders to launch “vaccine packages” not only to provide swift vaccinations but also to revive inbound tourism.
Scammers, racketeers, and criminal organizations have in so many ways sabotaged the global fight against the virus, by exploiting pandemic-related trade activities and profiting illegally from it. A case in point is Vietnam-based Mr. Hua Hong Hai who, posing as chairman of a medical product manufacturing company, has defrauded several companies of millions of dollars.
Contracting healthcare to Centers of Excellence is not a new model, employers have been leveraging these programs to provide quality healthcare at lower costs to their employees. However, with the economic downturn and pent-up demand for healthcare triggered by the coronavirus pandemic, the paradigm of health will shift toward this model - more self-funded employers will adopt this healthcare plan to minimize healthcare spendings while optimizing clinical outcomes for their employees
A COVID-19 vaccine is an important first step in making travel safe again, but it will not solve everything overnight. Nonetheless, it may open borders to vaccinated travelers and ease the fears of those seeking to travel for medical purposes.
As lockdown restrictions are being lifted across the globe, travel is gradually recovering, but with lessons learned that may stay that way for years to come. The pandemic will usher in a new normal for the travel industry, one that will prioritize health, safety, and sustainability.
Telemedicine has proven to be an effective and safe platform for doctors to reach patients during this global crisis, with the potential to ramp up diagnostic and treatment services as the world battles with the pandemic
Even though the pandemic remains under control in most parts of Southeast Asia, the erratic nature of the infection has discouraged authorities from opening up their borders and also dissuaded patients from visiting medical travel destinations still battling with the pandemic
N95 masks offer the highest level of respiratory protection by face coverings - filtering out up to 95% of the tiniest infectious particles. Global Healthcare Resources has found a way for everyone to access N95’s in small quantities and at affordable costs
Cedars-Sinai Medical Center in Los Angeles, California, has been awarded Accreditation for a three-year term by the Global Healthcare Accreditation (GHA) Program for its Medical Travel Services Program.
With the pandemic restrictions creating pent-up demand for elective procedures, more employees are willing to explore medical travel in countries like Korea to access safe and affordable healthcare.
While scientists continue to investigate and seek a better understanding of ivermectin and its use in COVID-19, emerging results have been promising.
In one of the swiftest vaccine developments in history, global teams of drugmakers, researchers, and scientists laid the groundwork that spurred the production of vaccines to end the coronavirus pandemic.
Stem cell therapy offers a promising treatment approach to COVID-19 due to their immunomodulatory and regenerative properties.
The challenges posed by the pandemic accelerated the paradigm shift in healthcare, speeding up the integration of digital healthcare solutions to bridge the gaps in patient care and those induced by the health crisis.